MYCN and neuroblastoma: Fourth, while the clinical course clearly indicates that all patients have high‐risk neuroblastoma, most patients in this study were initially treated at other institutions; therefore, data on biological characteristics of the tumor are insufficient at the time of the initial diagnosis, which is necessary for proper risk classification, such as ploidy and 11q loss, other than MYCN.